Prostate cancer: New types of radiotherapy improve cancer outcome but at what cost?

Abstract

New and very expensive forms of radiotherapy, such as intensity-modulated radiation therapy and proton therapy, have taken over the localized prostate cancer market. But is there enough evidence to justify their increased utilization and if so, how can we possibly afford them? © 2012 Macmillan Publishers Limited. All rights reserved.